To determine the effectiveness of lifestyle interventions and metformin in preventing or delaying multimorbidity in adults with prediabetes, with a focus on comparing these interventions to placebo.
Key Findings:
Participants in the lifestyle intervention had a 21% lower risk for two chronic conditions and a 25% lower risk for three chronic conditions compared to the placebo group, with 85% of the overall study population experiencing two or more chronic conditions by the end of follow-up.
Participants assigned to metformin did not show a statistically significant reduction in multimorbidity risk.
85% of participants experienced two or more chronic conditions by the end of follow-up.
Interpretation:
Lifestyle interventions significantly lower the risk of developing multiple chronic conditions in adults with prediabetes, while metformin did not demonstrate similar benefits, highlighting the need for public health initiatives.
Limitations:
The study primarily focused on participants enrolled in Medicare, which may limit generalizability and introduce biases.
The long duration of the study may introduce various confounding factors over time.
Conclusion:
Lifestyle modifications can effectively reduce the risk of multimorbidity, suggesting a need for sustained healthy behaviors and ongoing support among individuals at risk of diabetes.
"AI could help reduce the burden on ophthalmology services by triaging large numbers of patients with diabetes and allowing specialists to focus on those who most urgently need care."